共 31 条
[1]
Redrow GP(2016)Upper tract urothelial carcinoma: epidemiology, high risk populations and detection Minerva Urol Nefrol 68 350-358
[2]
Matin SF(2000)Upper tract urothelial neoplasms: incidence and survival during the last 2 decades J Urol 164 1523-1525
[3]
Munoz JJ(2010)The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center Eur Urol 58 574-580
[4]
Ellison LM(2012)Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature Eur Urol 62 100-114
[5]
Favaretto RL(2020)Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial Lancet 395 1268-1277
[6]
Shariat SF(2021)Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma N Engl J Med 384 2102-2114
[7]
Chade DC(2016)The 2016 WHO classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours Eur Urol 70 106-119
[8]
Lughezzani G(1982)Evaluating the yield of medical tests JAMA 247 2543-2546
[9]
Burger M(2021)Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol 22 525-537
[10]
Margulis V(2022)The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis Urol Oncol 40 243-261